Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,703 | 26 | 84.1% |
| Food and Beverage | $4,342 | 58 | 10.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,250 | 1 | 2.9% |
| Travel and Lodging | $1,153 | 6 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $19,300 | 23 | $0 (2024) |
| GENZYME CORPORATION | $6,161 | 5 | $0 (2024) |
| Stryker Corporation | $4,607 | 14 | $0 (2018) |
| Genentech, Inc. | $2,680 | 1 | $0 (2020) |
| Eli Lilly and Company | $2,400 | 1 | $0 (2024) |
| Chitogel Limited | $2,250 | 3 | $0 (2022) |
| ALK-Abello, Inc | $1,433 | 6 | $0 (2019) |
| Medtronic USA, Inc. | $1,075 | 14 | $0 (2020) |
| Medtronic, Inc. | $901.00 | 8 | $0 (2024) |
| Intersect ENT, Inc. | $501.17 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,092 | 11 | GENZYME CORPORATION ($6,134) |
| 2023 | $1,973 | 6 | Optinose US, Inc. ($1,788) |
| 2022 | $3,740 | 10 | OptiNose US, Inc. ($2,232) |
| 2021 | $3,141 | 5 | Chitogel Limited ($1,750) |
| 2020 | $4,545 | 5 | Genentech, Inc. ($2,680) |
| 2019 | $12,686 | 18 | OptiNose US, Inc. ($10,929) |
| 2018 | $5,561 | 27 | Stryker Corporation ($4,607) |
| 2017 | $711.79 | 9 | Medtronic USA, Inc. ($365.04) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Immunology | ||||||
| 12/02/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,752.00 | General |
| 10/16/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,346.00 | General |
| 08/21/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $40.49 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/03/2024 | Optinose US, Inc. | Xhance (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/24/2024 | Medtronic, Inc. | STEALTHSTATION S8 PLATFORM (Device) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Image Guided Surgery Products | ||||||
| 05/15/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $176.38 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Immunology | ||||||
| 01/29/2024 | Medtronic, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $187.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/04/2023 | Optinose US, Inc. | Xhance (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/08/2023 | Medtronic, Inc. | STEALTHSTATION S8 PLATFORM (Device) | Food and Beverage | In-kind items and services | $110.01 | General |
| Category: Image Guided Surgery Products | ||||||
| 11/08/2023 | Medtronic, Inc. | STEALTHSTATION S8 PLATFORM (Device) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Image Guided Surgery Products | ||||||
| 09/30/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $137.54 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/11/2023 | Optinose US, Inc. | Xhance (Drug) | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/19/2023 | Medtronic, Inc. | STEALTHSTATION S8 PLATFORM (Device) | Food and Beverage | In-kind items and services | $59.31 | General |
| Category: Image Guided Surgery Products | ||||||
| 09/30/2022 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Generator | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 09/21/2022 | Chitogel Limited | Chitogel Endoscopic Sinus Surgery Kit (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: ENT | ||||||
| 09/19/2022 | OptiNose US, Inc. | Xhance (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/16/2022 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $87.23 | General |
| 09/15/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/06/2022 | Medtronic, Inc. | NUVENT (Device) | Food and Beverage | In-kind items and services | $250.12 | General |
| Category: Sinus Surgery | ||||||
| 08/29/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $166.13 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/29/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $44.53 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 262 | 339 | $229,336 | $39,645 |
| 2022 | 6 | 246 | 330 | $229,753 | $42,037 |
| 2021 | 6 | 219 | 280 | $181,623 | $36,394 |
| 2020 | 6 | 160 | 205 | $119,881 | $21,686 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 96 | 126 | $110,582 | $17,489 | 15.8% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 20 | 33 | $46,098 | $6,574 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 76 | $23,900 | $5,193 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 55 | $24,530 | $5,105 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $15,879 | $3,429 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $8,347 | $1,855 | 22.2% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 87 | 110 | $92,340 | $16,130 | 17.5% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 21 | 47 | $74,508 | $11,665 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 90 | $26,670 | $5,861 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 35 | $14,810 | $3,528 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $12,006 | $2,706 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $9,419 | $2,146 | 22.8% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 81 | 107 | $87,441 | $16,379 | 18.7% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2021 | 14 | 28 | $41,796 | $6,707 | 16.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 61 | $16,212 | $4,446 | 27.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $15,324 | $3,677 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 33 | $12,545 | $3,301 | 26.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $8,305 | $1,884 | 22.7% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2020 | 53 | 73 | $58,813 | $10,354 | 17.6% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2020 | 16 | 21 | $30,964 | $4,826 | 15.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 61 | $14,832 | $3,309 | 22.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 22 | $7,796 | $1,531 | 19.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $5,682 | $1,253 | 22.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 12 | $1,794 | $411.86 | 23.0% |
About Dr. Sarah Wise, MD
Dr. Sarah Wise, MD is a Otolaryngology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053348060.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Wise, MD has received a total of $42,448 in payments from pharmaceutical and medical device companies, with $10,092 received in 2024. These payments were reported across 91 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($35,703).
As a Medicare-enrolled provider, Wise has provided services to 887 Medicare beneficiaries, totaling 1,154 services with total Medicare billing of $139,760. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology, Otolaryngic Allergy
- Location Atlanta, GA
- Active Since 06/26/2006
- Last Updated 01/24/2022
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1053348060
Products in Payments
- Xhance (Drug) $19,300
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $4,607
- Xolair (Biological) $2,680
- Chitogel Endoscopic Sinus Surgery Kit (Device) $2,250
- Odactra (Drug) $1,433
- NEUROMARK Device (Device) $500.00
- STRAIGHTSHOT (Device) $479.90
- FUSION (Device) $445.29
- PROPEL (Device) $417.39
- SINUVA (Drug) $270.78
- NUVENT (Device) $250.12
- Clarifix (Device) $210.83
- STEALTHSTATION S8 PLATFORM (Device) $206.04
- Vivaer RF Stylus (Device) $136.24
- XprESS Multi-Sinus Dilation System (Device) $120.92
- VIVAER STYLUS (Device) $40.49
- DUPIXENT (Biological) $36.46
- NUCALA (Biological) $32.38
- ASTHMA - DISEASE (Drug) $26.36
- Auvi-Q (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Atlanta
Dr. Jose Stolovitzky, M.d, M.D
Otolaryngology — Payments: $579,544
Dr. Karen Hoffmann, M.d, M.D
Otolaryngology — Payments: $214,163
Mihir Patel, Md, MD
Otolaryngology — Payments: $174,482
John Delgaudio, M.d, M.D
Otolaryngology — Payments: $94,037
Dr. Elizabeth Whitaker, M.d, M.D
Otolaryngology — Payments: $23,386
Nicole Schmitt, M.d, M.D
Otolaryngology — Payments: $12,484